title: [Side effects of temozolomide treatment in patient with glioblastoma multiforme--case study].
abstract: In case study, we presented patient with glioblastoma multiforme-brain tumor-grade IV-WHO. Patient after surgery, followed by radiotherapy and chemotherapy, after cycles of chemotherapy with temozolomid. During therapy with temozolomid, it is recommended to check morphology on the 22nd day of cycle. Patient did not come for follow-up appointment, also she did not do any of follow-up tests. She came to the hospital 2 weeks later, in poor general condition with peripheral pancytopenia, neurological disorders and shortness of breath.
authors.affiliation: Szpital Wojewódzki im. Sw. Łukasza Tarnów Oddział Wewnetrzny II i Ostrych Zatruć.
authors.forename: Stanisław
authors.initials: S
authors.lastname: Łata
authors.forename: Anna
authors.initials: A
authors.lastname: Molczyk
mesh_terms: D018906:Antineoplastic Agents, Alkylating / Q000009:adverse effects*; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D003606:Dacarbazine / Q000009:adverse effects / Q000031:analogs & derivatives*; D005260:Female; D005909:Glioblastoma / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery; D006801:Humans; D008875:Middle Aged; D009422:Nervous System Diseases / Q000139:chemically induced*; D010198:Pancytopenia / Q000139:chemically induced*; D018714:Radiotherapy, Adjuvant; D000077204:Temozolomide
chemical_list: D018906:Antineoplastic Agents, Alkylating; D003606:Dacarbazine; D000077204:Temozolomide